Abstract
Systemic sclerosis (SSc) is a multisystemic disorder characterized by functional and structural abnormalities of small blood vessels and fibrosis of the skin and internal organs. Eighty percent of subjects with SSc have orofacial manifestations. No tests for oral manifestations have been validated for this pathology, and in the literature there are few studies of speech therapy for subjects with SSc. These facts suggested the need for an exhaustive assessment of mouth mobility and muscle strength, and also of swallowing and voice, in order to plan a targeted and effective speech therapy. The Scleroderma Logopedic Scale (SLS) has been developed to assess disorders in five domains: Impairment, Swallow, Voice, Multifield, and Quality of Life. Perception of these disorders was assessed in 84 subjects with SSc and in 40 healthy subjects. After the first draft, a shorter form (39 items) was obtained after statistical analysis. This scale showed good discriminant and concurrent validity. Internal consistency was good: three of five subscales had a Cronbach α coefficient higher than 0.8. The test/retest coefficient for the total score was 0.94. Thirty-six percent of examined subjects showed moderate to severe oropharyngolaryngeal disorders. Swallowing disorders and impairment of mouth (e.g., decrease in mobility and strength) were the most commonly reported problems. Conversely, the change of voice due to the pathology was not perceived as a problem. Fifty-five percent of subjects reported a decreased level of quality of life.
Similar content being viewed by others
References
Ntoumazios SK, Voulgari PV, Potsis K, Koutis E, Tsifetaki N, Assimakopoulos DA. Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem. Semin Arthritis Rheum. 2006;36:173–81. doi:10.1016/j.semarthrit.2006.08.002.
Rout PG, Hamburger J, Potts AJ. Orofacial radiological manifestations of systemic sclerosis. Dentomaxillofac Radiol. 1996;25:193–6.
Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G, et al. Systemic Sclerosis Study Group of the Italian Society of Rheumatology, (SIR-GSSSc): systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine. 2002;81:139–53. doi:10.1097/00005792-200203000-00004.
Valentini G, Black C. Systemic sclerosis. Best Pract Res Clin Rheumatol. 2002;16:807–16. doi:10.1053/berh.2002.0258.
Pizzo G, Scardina GA, Messina P. Effects of a nonsurgical exercise program on the decreased mouth opening in patients with systemic scleroderma. Clin Oral Investig. 2003;7:175–8. doi:10.1007/s00784-003-0216-5.
Menditti D, Palomba F, Rullo R, Minervini G. Progressive systemic sclerosis (scleroderma): oral manifestations. Arch Stomatol. 1990;31:537–48.
Scardina GA, Mazzullo M, Messina P. Early diagnosis of Progressive Systemic Sclerosis: the role of orofacial phenomena. Minerva Stomatol. 2002;51:311–7.
Nagy G, Kovács J, Zeher M, Czirják L. Analysis of the oral manifestations of systemic sclerosis. Oral Surg Oral Med Oral Pathol. 1994;77:141–6. doi:10.1016/0030-4220(94)90276-3.
Terzioğlu A, Ciğşar B, Aslan G. Surgical correction of microstomia in a patient with scleroderma. Ann Plast Surg. 2002;49:222–3. doi:10.1097/00000637-200208000-00028.
Naylor WP, Douglass CW, Mix E. The nonsurgical treatment of microstomia in scleroderma: a pilot study. Oral Surg Oral Med Oral Pathol. 1984;57:508–11. doi:10.1016/0030-4220(84)90309-8.
Poole JL, Brewer C, Rossie K, Good CC, Conte C, Steen V. Factors related to oral hygiene in persons with scleroderma. Int J Dent Hyg. 2005;3:13–7. doi:10.1111/j.1601-5037.2004.00108.x.
Biotto C (2006) Sclerosi Sistemica: elaborazione e somministrazione di un protocollo di valutazione logopedica. Analisi e sintesi dei dati raccolti. Bachelor’s Thesis, University of Milan, November 2006
Enderby P, John A, Petherham B. Therapy Outcome Measures manual: physiotherapy, occupational therapy, rehabilitation nursing. San Diego, CA: Singular; 1998.
Yorkston KM, Bombardier C, Hammer V. Dysarthria from the view point of individuals with dysarthria. In: Till JA, Yorkston KM, Beukelman DR, editors. Motor speech disorders. Advances in assessment and treatment. Toronto: Brooks Publishing; 1994.
De Bodt MS, Wuyts FL, Van de Heyning PH, Croux C. Test-retest study of the GRBAS scale: influence of experience and professional background on perceptual rating of voice quality. J Voice. 1997;11:74–80. doi:10.1016/S0892-1997(97)80026-4.
Apolone G, Mosconi P. The Italian SF-36 health survey: translation, validation and norming. J Clin Epidemiol. 1998;51:1025–36. doi:10.1016/S0895-4356(98)00094-8.
Haynes BF, Soderberg KA, Fauci AS. Disorders of the immune system, connective tissue, and joints. In: Harrison, editor. Principi di medicina interna. 14th ed. Milan: McGraw-Hill; 1999. p. 2153–62.
Scorza R, Caronni M, Mascagni B, Berruti V, Bazzi S, Micallef E, et al. Effects of long-term cyclic iloprost therapy in systemic sclerosis with Raynaud’s phenomenon. A randomized, controlled study. Clin Exp Rheumatol. 2001;19:503–8.
No authors listed, Appendix. Manual of signs, symptoms, methods and procedures for the assessment of the patient with SSc. Clin Exp Rheumatol 2003; 21:S49–S56
McHorney CA, Bricker DE, Kramer AE, Rosenbek JC, Robbins J, Chignell KA, et al. The SWAL-QOL outcomes tool for oropharyngeal dysphagia in adults: I. Conceptual foundation and item development. Dysphagia. 2000;15:115–21.
McHorney CA, Bricker DE, Robbins J, Kramer AE, Rosenbek JC, Chignell KA. The SWAL-QOL outcomes tool for oropharyngeal dysphagia in adults: II. Item reduction and preliminary scaling. Dysphagia. 2000;15:122–33.
McHorney CA, Robbins J, Lomax K, Rosenbek JC, Chignell K, Kramer AE, et al. The SWAL-QOL and SWAL-CARE outcomes tool for oropharyngeal dysphagia in adults: III. Documentation of reliability and validity. Dysphagia. 2002;17:97–114. doi:10.1007/s00455-001-0109-1.
Roe JW, Leslie P, Drinnan MJ. Oropharyngeal dysphagia: the experience of patients with non-head and neck cancers receiving specialist palliative care. Palliat Med. 2007;21:567–74. doi:10.1177/0269216307082656.
McHorney CA, Martin-Harris B, Robbins J, Rosenbek J. Clinical validity of the SWAL-QOL and SWAL-CARE outcome tools with respect to bolus flow measures. Dysphagia. 2006;21:141–8. doi:10.1007/s00455-005-0026-9.
Deary IJ, Webb A, Mackenzie K, Wilson JA, Carding PN. Short, self-report voice symptom scales: psychometric characteristics of the voice handicap index-10 and the vocal performance questionnaire. Otolaryngol Head Neck Surg. 2004;131:232–5. doi:10.1016/j.otohns.2004.02.048.
LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1998;15:202–5.
Medsger TA Jr, Bombardieri S, Scorza R, Della Rossa A, Bencivelli W. Assessment of disease severity and prognosis. Clin Exp Rheumatol. 2003;21(Suppl 29):S42–6.
Streiner DL, Norman GR. Health measurement scales. A practical guide to their development and use. 2nd ed. New York: Oxford University Press; 1996.
Anselmino M, Zaninotto G, Costantini M, Ostuni P, Ianniello A, Boccú C, et al. Esophageal motor function in primary Sjögren’s syndrome: correlation with dysphagia and xerostomia. Dig Dis Sci. 1997;42:113. doi:10.1023/A:1018845323765.
Helm JF. Role of saliva in esophageal function and disease. Dysphagia. 1989;4:76–84. doi:10.1007/BF02407149.
Sonies BC, Ship JA, Baum BJ. Relationship between saliva production and oropharyngeal swallow in healthy, different-aged adults. Dysphagia. 1989;4:85–9. doi:10.1007/BF02407150.
Karkos PD, Yates PD, Carding PN, Wilson JA. Is laryngopharyngeal reflux related to functional dysphonia? Ann Otol Rhinol Laryngol. 2007;116:24–9.
Makhadoom N, Abouloyoun A, Bokhary HA, Dhafar KO, Gazzaz ZJ, Azab BA. Prevalence of gastroesophageal reflux disease in patients with laryngeal and voice disorders. Saudi Med J. 2007;28:1068–71.
Portney LG, Watkins MP. Foundations of clinical research; application to practice. Upper Saddle River, NJ: Prentice Hall Health; 1999. p. 560–8.
Montesi A, Pesaresi A, Cavalli ML, Ripa G, Candela M, Gabrielli A. Oropharyngeal and esophageal function in scleroderma. Dysphagia. 1991;6:219–23. doi:10.1007/BF02493531.
Beretta L, Astori S, Ferrario E, Caronni M, Raimondi M, Scorza R. Determinants of depression in 111 Italian patients with systemic sclerosis. Reumatismo. 2006;58:219–25.
Cossutta R, Zeni S, Soldi A, Colombelli P, Belotti Masserini A, Fantini F. Evaluation of quality of life in patients with systemic sclerosis by administering the SF-36 questionnaire. Reumatismo. 2002;54:122–7.
Acknowledgment
This work was supported by the GILS (Gruppo Italiano Lotta alla Sclerodermia).
Author information
Authors and Affiliations
Corresponding author
Appendix: Abbreviated Item Content in the Long and Short Form of the Scale
Appendix: Abbreviated Item Content in the Long and Short Form of the Scale
58-Item scale | 39-Item scale | Item content |
---|---|---|
Impairment | ||
1 | 29 | Xerostomia |
2 | 1 | Gingival resorption |
3 | – | Face tingling |
4 | – | Mouth inflammation |
5 | – | Taste |
6 | – | Smell |
7 | 2 | Mouth opening |
8 | 3 | Mouth opening |
9 | 4 | Mouth opening |
10 | 5 | Lip resorption |
11 | – | Muscle rigidity |
12 | 6 | Muscle rigidity |
13 | 7 | Muscle rigidity |
14 | 8 | Muscle weakness |
15 | – | Muscle weakness |
16 | – | Muscle weakness |
Disability | ||
Swallowing | ||
17 | 14 | Biting |
18 | 15 | Chewing |
19 | 16 | Chewing |
20 | – | Chewing |
21 | – | Chewing |
22 | 17 | Swallowing |
23 | 18 | Tongue mobility |
24 | 19 | Food characteristics |
25 | 20 | Food characteristics |
26 | 21 | Food characteristics |
27 | 22 | Duration of meal |
28 | 23 | Food leaking from mouth |
29 | 24 | Bolus transit |
30 | 25 | Bolus transit |
31 | 26 | Bolus sticking |
32 | 27 | Xerostomia |
33 | 28 | Aspiration |
34 | – | Aspiration |
Voice | ||
35 | 9 | Running out of air |
36 | 10 | Loudness |
37 | 11 | Roughness |
38 | 12 | Fatigue |
39 | – | Weariness |
40 | 13 | Loudness |
41 | – | Running out of air |
42 | – | Xerostomia |
Multifield | ||
43 | 30 | Gastroesophageal reflux |
44 | 31 | Mouth opening |
45 | – | Mouth opening |
46 | – | Mouth opening |
47 | 32 | Oral hygiene |
48 | – | Face tingling |
49 | 33 | Facial expression |
50 | 34 | Muscle rigidity |
Quality of life | ||
51 | 35 | Facial expression |
52 | 36 | Eating pleasure |
53 | 37 | Oropharyngolaryngeal symptoms |
54 | 38 | Oropharyngolaryngeal symptoms |
55 | 39 | Quality of life |
56 | – | Eating pleasure |
57 | – | Eating pleasure |
58 | – | Speaking pleasure |
Rights and permissions
About this article
Cite this article
Vitali, C., Borghi, E., Napoletano, A. et al. Oropharyngolaryngeal Disorders in Scleroderma: Development and Validation of the SLS Scale. Dysphagia 25, 127–138 (2010). https://doi.org/10.1007/s00455-009-9235-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00455-009-9235-y